Licensing Opportunities

Sanquin offers a broad range of licensing opportunities and monoclonal antibodies.

Current licensing opportunities

Patent application WO/2009/089846
Patent application EP2111869A1
Patent nr. US12/998,595
Patent application EP14181631.4
Patent application EP15197875, filed: December 3rd, 2015
Patent application: EP16161212, filed 18 March 2016
Last edited on: 24 August 2016